nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—CYP1B1—Mitoxantrone—lymphatic system cancer	0.225	0.258	CbGbCtD
Caffeine—CYP1A2—Carmustine—lymphatic system cancer	0.0937	0.107	CbGbCtD
Caffeine—CYP3A5—Teniposide—lymphatic system cancer	0.0846	0.0971	CbGbCtD
Caffeine—CYP2E1—Mitoxantrone—lymphatic system cancer	0.0762	0.0874	CbGbCtD
Caffeine—CYP2C9—Teniposide—lymphatic system cancer	0.0568	0.0651	CbGbCtD
Caffeine—CYP3A7—Vincristine—lymphatic system cancer	0.0543	0.0623	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0543	0.0623	CbGbCtD
Caffeine—CYP3A5—Vincristine—lymphatic system cancer	0.0407	0.0467	CbGbCtD
Caffeine—ABCB1—Mitoxantrone—lymphatic system cancer	0.0385	0.0442	CbGbCtD
Caffeine—CYP3A4—Cytarabine—lymphatic system cancer	0.0335	0.0384	CbGbCtD
Caffeine—CYP3A4—Teniposide—lymphatic system cancer	0.033	0.0379	CbGbCtD
Caffeine—ABCB1—Vincristine—lymphatic system cancer	0.0265	0.0304	CbGbCtD
Caffeine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0231	0.0265	CbGbCtD
Caffeine—ABCB1—Methotrexate—lymphatic system cancer	0.0161	0.0184	CbGbCtD
Caffeine—CYP3A4—Vincristine—lymphatic system cancer	0.0159	0.0182	CbGbCtD
Caffeine—PRKDC—Vinblastine—Vincristine—lymphatic system cancer	0.00749	1	CbGdCrCtD
Caffeine—Impaired healing—Carmustine—lymphatic system cancer	0.00435	0.036	CcSEcCtD
Caffeine—Haemoglobin decreased—Fludarabine—lymphatic system cancer	0.00427	0.0354	CcSEcCtD
Caffeine—Cerebral haemorrhage—Carmustine—lymphatic system cancer	0.00339	0.0282	CcSEcCtD
Caffeine—Cerebral haemorrhage—Vincristine—lymphatic system cancer	0.00324	0.0269	CcSEcCtD
Caffeine—Sepsis—Teniposide—lymphatic system cancer	0.0029	0.024	CcSEcCtD
Caffeine—Haemoglobin decreased—Mitoxantrone—lymphatic system cancer	0.00254	0.0211	CcSEcCtD
Caffeine—Deafness—Fludarabine—lymphatic system cancer	0.00238	0.0198	CcSEcCtD
Caffeine—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.00229	0.019	CcSEcCtD
Caffeine—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.00228	0.0189	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Fludarabine—lymphatic system cancer	0.00213	0.0177	CcSEcCtD
Caffeine—Accidental injury—Carmustine—lymphatic system cancer	0.00212	0.0176	CcSEcCtD
Caffeine—Impaired healing—Methotrexate—lymphatic system cancer	0.00201	0.0167	CcSEcCtD
Caffeine—Injury—Bleomycin—lymphatic system cancer	0.0017	0.0141	CcSEcCtD
Caffeine—Haemoglobin—Teniposide—lymphatic system cancer	0.00169	0.014	CcSEcCtD
Caffeine—Haemorrhage—Teniposide—lymphatic system cancer	0.00168	0.0139	CcSEcCtD
Caffeine—Hyperglycaemia—Fludarabine—lymphatic system cancer	0.00166	0.0138	CcSEcCtD
Caffeine—Sepsis—Carmustine—lymphatic system cancer	0.00163	0.0135	CcSEcCtD
Caffeine—Urine output increased—Vincristine—lymphatic system cancer	0.00162	0.0135	CcSEcCtD
Caffeine—Renal failure—Fludarabine—lymphatic system cancer	0.00161	0.0134	CcSEcCtD
Caffeine—Infection—Mechlorethamine—lymphatic system cancer	0.00161	0.0133	CcSEcCtD
Caffeine—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00157	0.013	CcSEcCtD
Caffeine—Sepsis—Mitoxantrone—lymphatic system cancer	0.00152	0.0126	CcSEcCtD
Caffeine—Injury—Carmustine—lymphatic system cancer	0.00148	0.0123	CcSEcCtD
Caffeine—Haemoglobin—Fludarabine—lymphatic system cancer	0.00148	0.0123	CcSEcCtD
Caffeine—Haemorrhage—Fludarabine—lymphatic system cancer	0.00147	0.0122	CcSEcCtD
Caffeine—Deafness—Vincristine—lymphatic system cancer	0.00146	0.0121	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Carmustine—lymphatic system cancer	0.00136	0.0113	CcSEcCtD
Caffeine—Agitation—Teniposide—lymphatic system cancer	0.00134	0.0111	CcSEcCtD
Caffeine—Malnutrition—Fludarabine—lymphatic system cancer	0.00128	0.0106	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Mitoxantrone—lymphatic system cancer	0.00127	0.0105	CcSEcCtD
Caffeine—Hypertension—Teniposide—lymphatic system cancer	0.00126	0.0105	CcSEcCtD
Caffeine—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00119	0.00988	CcSEcCtD
Caffeine—Blood creatinine increased—Mitoxantrone—lymphatic system cancer	0.00119	0.00985	CcSEcCtD
Caffeine—Infection—Teniposide—lymphatic system cancer	0.00118	0.00982	CcSEcCtD
Caffeine—Agitation—Fludarabine—lymphatic system cancer	0.00118	0.00978	CcSEcCtD
Caffeine—Tachycardia—Teniposide—lymphatic system cancer	0.00116	0.00965	CcSEcCtD
Caffeine—Convulsion—Fludarabine—lymphatic system cancer	0.00111	0.00922	CcSEcCtD
Caffeine—Haemoglobin—Bleomycin—lymphatic system cancer	0.00109	0.00901	CcSEcCtD
Caffeine—Haemorrhage—Bleomycin—lymphatic system cancer	0.00108	0.00897	CcSEcCtD
Caffeine—Hyperglycaemia—Carmustine—lymphatic system cancer	0.00106	0.00882	CcSEcCtD
Caffeine—Dyspnoea—Teniposide—lymphatic system cancer	0.00106	0.00881	CcSEcCtD
Caffeine—Infection—Fludarabine—lymphatic system cancer	0.00104	0.00863	CcSEcCtD
Caffeine—Renal failure—Carmustine—lymphatic system cancer	0.00103	0.00857	CcSEcCtD
Caffeine—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00103	0.00852	CcSEcCtD
Caffeine—Rash—Mechlorethamine—lymphatic system cancer	0.00102	0.00845	CcSEcCtD
Caffeine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00102	0.00845	CcSEcCtD
Caffeine—Hyperglycaemia—Mitoxantrone—lymphatic system cancer	0.000989	0.0082	CcSEcCtD
Caffeine—Renal failure—Mitoxantrone—lymphatic system cancer	0.000961	0.00797	CcSEcCtD
Caffeine—Haemoglobin—Carmustine—lymphatic system cancer	0.000948	0.00787	CcSEcCtD
Caffeine—Haemorrhage—Carmustine—lymphatic system cancer	0.000944	0.00783	CcSEcCtD
Caffeine—Dyspnoea—Fludarabine—lymphatic system cancer	0.000934	0.00775	CcSEcCtD
Caffeine—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000904	0.0075	CcSEcCtD
Caffeine—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.000882	0.00731	CcSEcCtD
Caffeine—Hypersensitivity—Teniposide—lymphatic system cancer	0.000878	0.00728	CcSEcCtD
Caffeine—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000877	0.00728	CcSEcCtD
Caffeine—Cardiac disorder—Vincristine—lymphatic system cancer	0.000836	0.00693	CcSEcCtD
Caffeine—Malnutrition—Carmustine—lymphatic system cancer	0.000821	0.00681	CcSEcCtD
Caffeine—Urine output increased—Methotrexate—lymphatic system cancer	0.000787	0.00653	CcSEcCtD
Caffeine—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.000775	0.00643	CcSEcCtD
Caffeine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000772	0.0064	CcSEcCtD
Caffeine—Infection—Bleomycin—lymphatic system cancer	0.000763	0.00633	CcSEcCtD
Caffeine—Sepsis—Methotrexate—lymphatic system cancer	0.000755	0.00626	CcSEcCtD
Caffeine—Agitation—Carmustine—lymphatic system cancer	0.000755	0.00626	CcSEcCtD
Caffeine—Rash—Teniposide—lymphatic system cancer	0.000752	0.00623	CcSEcCtD
Caffeine—Dermatitis—Teniposide—lymphatic system cancer	0.000751	0.00623	CcSEcCtD
Caffeine—Agitation—Vincristine—lymphatic system cancer	0.000721	0.00598	CcSEcCtD
Caffeine—Convulsion—Carmustine—lymphatic system cancer	0.000712	0.0059	CcSEcCtD
Caffeine—Hypertension—Carmustine—lymphatic system cancer	0.000709	0.00588	CcSEcCtD
Caffeine—Dyspnoea—Bleomycin—lymphatic system cancer	0.000685	0.00568	CcSEcCtD
Caffeine—Convulsion—Vincristine—lymphatic system cancer	0.000679	0.00564	CcSEcCtD
Caffeine—Hypertension—Vincristine—lymphatic system cancer	0.000677	0.00562	CcSEcCtD
Caffeine—Infection—Carmustine—lymphatic system cancer	0.000666	0.00552	CcSEcCtD
Caffeine—Convulsion—Mitoxantrone—lymphatic system cancer	0.000662	0.00549	CcSEcCtD
Caffeine—Rash—Fludarabine—lymphatic system cancer	0.000661	0.00548	CcSEcCtD
Caffeine—Dermatitis—Fludarabine—lymphatic system cancer	0.00066	0.00547	CcSEcCtD
Caffeine—Hypertension—Mitoxantrone—lymphatic system cancer	0.000659	0.00547	CcSEcCtD
Caffeine—Tachycardia—Carmustine—lymphatic system cancer	0.000654	0.00543	CcSEcCtD
Caffeine—Infection—Vincristine—lymphatic system cancer	0.000636	0.00527	CcSEcCtD
Caffeine—Nervous system disorder—Vincristine—lymphatic system cancer	0.000628	0.00521	CcSEcCtD
Caffeine—Infection—Mitoxantrone—lymphatic system cancer	0.000619	0.00514	CcSEcCtD
Caffeine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000608	0.00505	CcSEcCtD
Caffeine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000605	0.00502	CcSEcCtD
Caffeine—Irritability—Methotrexate—lymphatic system cancer	0.000603	0.005	CcSEcCtD
Caffeine—Dyspnoea—Carmustine—lymphatic system cancer	0.000598	0.00496	CcSEcCtD
Caffeine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000579	0.0048	CcSEcCtD
Caffeine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000566	0.00469	CcSEcCtD
Caffeine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000556	0.00461	CcSEcCtD
Caffeine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000553	0.00458	CcSEcCtD
Caffeine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000494	0.0041	CcSEcCtD
Caffeine—Infestation NOS—Methotrexate—lymphatic system cancer	0.000487	0.00404	CcSEcCtD
Caffeine—Infestation—Methotrexate—lymphatic system cancer	0.000487	0.00404	CcSEcCtD
Caffeine—Rash—Bleomycin—lymphatic system cancer	0.000484	0.00402	CcSEcCtD
Caffeine—Dermatitis—Bleomycin—lymphatic system cancer	0.000484	0.00401	CcSEcCtD
Caffeine—Renal failure—Methotrexate—lymphatic system cancer	0.000479	0.00397	CcSEcCtD
Caffeine—Hypersensitivity—Vincristine—lymphatic system cancer	0.000472	0.00391	CcSEcCtD
Caffeine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000459	0.00381	CcSEcCtD
Caffeine—Haemoglobin—Methotrexate—lymphatic system cancer	0.000439	0.00364	CcSEcCtD
Caffeine—Haemorrhage—Methotrexate—lymphatic system cancer	0.000437	0.00363	CcSEcCtD
Caffeine—Rash—Carmustine—lymphatic system cancer	0.000423	0.00351	CcSEcCtD
Caffeine—Dermatitis—Carmustine—lymphatic system cancer	0.000422	0.0035	CcSEcCtD
Caffeine—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000406	0.00336	CcSEcCtD
Caffeine—Rash—Vincristine—lymphatic system cancer	0.000404	0.00335	CcSEcCtD
Caffeine—Dermatitis—Vincristine—lymphatic system cancer	0.000403	0.00334	CcSEcCtD
Caffeine—Immune system disorder—Methotrexate—lymphatic system cancer	0.000395	0.00327	CcSEcCtD
Caffeine—Rash—Mitoxantrone—lymphatic system cancer	0.000393	0.00326	CcSEcCtD
Caffeine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000393	0.00326	CcSEcCtD
Caffeine—Malnutrition—Methotrexate—lymphatic system cancer	0.000381	0.00316	CcSEcCtD
Caffeine—Convulsion—Methotrexate—lymphatic system cancer	0.00033	0.00273	CcSEcCtD
Caffeine—Infection—Methotrexate—lymphatic system cancer	0.000309	0.00256	CcSEcCtD
Caffeine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000305	0.00253	CcSEcCtD
Caffeine—Skin disorder—Methotrexate—lymphatic system cancer	0.000302	0.0025	CcSEcCtD
Caffeine—Dyspnoea—Methotrexate—lymphatic system cancer	0.000277	0.0023	CcSEcCtD
Caffeine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000268	0.00222	CcSEcCtD
Caffeine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000229	0.0019	CcSEcCtD
Caffeine—Rash—Methotrexate—lymphatic system cancer	0.000196	0.00162	CcSEcCtD
Caffeine—Dermatitis—Methotrexate—lymphatic system cancer	0.000196	0.00162	CcSEcCtD
